Literature DB >> 30819421

Dilated cardiomyopathy in 151 Irish Wolfhounds: Characteristic clinical findings, life expectancy and causes of death.

C Vollmar1, A Vollmar2, B W Keene3, P R Fox4, S Reese5, B Kohn6.   

Abstract

Dilated cardiomyopathy (DCM) is an important cause of morbidity in Irish Wolfhounds (IW), a breed also predisposed to neoplastic and orthopedic diseases that shorten life expectancy. The objective of this study was to investigate survival and causes of death in IW with DCM and to characterise the clinical findings of DCM over time. Data from cardiovascular examinations performed in 1591 IW, including echocardiography and electrocardiography, were retrospectively evaluated. IW with DCM on medical therapy with long term longitudinal follow-up were included in this study (n=151; 95 males, 56 females). Based on their clinical status at initial diagnosis, IW were classified into one of three groups: preclinical DCM with sinus rhythm (PC-DCM-SR, n=35), preclinical DCM with atrial fibrillation (PC-DCM-AF, n=87), and congestive heart failure with DCM and AF (CHF-DCM-AF, n=29). Survival data were analyzed using cumulative incidence functions, Kaplan-Meier and Cox regression. CHF was predominantly characterized by chylous pleural and mild pericardial effusions. Causes of death were cardiac (CD) in 73/151 and non-cardiac (non-CD) in 62/151; 16 dogs remained alive at study end. The majority of deaths in both preclinical DCM groups were non-CD (PC-DCM-AF=51.9% non-CD, 48.1% CD; PC-DCM-SR, 65.5% non-CD, 34.5% CD). In the CHF-DCM-AF group most dogs (89.6%) experienced a CD. Median survival of the CHF-DCM-AF group (7.3 months) was significantly shorter than in the PC-DCM-AF group (21.9 months) or PC-DCM-SR group (29.1 months, P=0.001). CHF-DCM-AF in IW was associated with reduced life expectancy and CD, while most IW with preclinical DCM died from non-cardiac causes.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Cardiac death; Congestive heart failure; Dogs; Sudden cardiac death

Mesh:

Year:  2018        PMID: 30819421     DOI: 10.1016/j.tvjl.2018.12.018

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  6 in total

1.  Retrospective study of dilated cardiomyopathy in dogs.

Authors:  Kimberly J Freid; Lisa M Freeman; John E Rush; Suzanne M Cunningham; Megan S Davis; Emily T Karlin; Vicky K Yang
Journal:  J Vet Intern Med       Date:  2020-12-21       Impact factor: 3.175

2.  Prospective study of dilated cardiomyopathy in dogs eating nontraditional or traditional diets and in dogs with subclinical cardiac abnormalities.

Authors:  Lisa Freeman; John Rush; Darcy Adin; Kelsey Weeks; Kristen Antoon; Sara Brethel; Suzanne Cunningham; Luis Dos Santos; Renee Girens; Robert Goldberg; Emily Karlin; Darleen Lessard; Katherine Lopez; Camden Rouben; Michelle Vereb; Vicky Yang
Journal:  J Vet Intern Med       Date:  2022-03-17       Impact factor: 3.333

3.  Prevalence of an angiotensin-converting enzyme gene variant in dogs.

Authors:  D B Adin; C E Atkins; S G Friedenberg; J A Stern; K M Meurs
Journal:  Canine Med Genet       Date:  2021-07-13

4.  Echocardiographic and electrocardiographic evaluation of North American Irish Wolfhounds.

Authors:  William D Tyrrell; Jonathan A Abbott; Steven L Rosenthal; Mariellen Dentino; Frances Abrams
Journal:  J Vet Intern Med       Date:  2020-02-29       Impact factor: 3.333

Review 5.  Review of canine dilated cardiomyopathy in the wake of diet-associated concerns.

Authors:  Sydney R McCauley; Stephanie D Clark; Bradley W Quest; Renee M Streeter; Eva M Oxford
Journal:  J Anim Sci       Date:  2020-06-01       Impact factor: 3.159

6.  Echocardiographic predictors of first onset of atrial fibrillation in dogs with myxomatous mitral valve disease.

Authors:  Marco Baron Toaldo; Chiara Mazzoldi; Giovanni Romito; Helen Poser; Barbara Contiero; Mario Cipone; Carlo Guglielmini
Journal:  J Vet Intern Med       Date:  2020-08-07       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.